RetiSpec is very proud to be featured in September's issue of Scientific American exploring how eye tests can help to diagnose Alzheimer's disease

The RetiSpec Mission
RetiSpec believes a better future for Alzheimer’s starts with the ability to diagnose it. Our mission is to enable widespread early and accurate detection of neurodegenerative disease markers, with accessible, affordable, and scalable retinal screening. To achieve this vision, RetiSpec is developing explainable AI (XAI) for the early detection of Alzheimer’s disease through a simple eye test.